Salt Lake City, Utah, June 02, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company, today announced that the Nasdaq Hearings Panel has granted the company an extension of time to comply with Nasdaq listing rules subject to panel conditions. The Company's listing will be transferred to the Capital Market, effective at the open of business on June 3, 2025.

Strategic acquisition would position Safe & Green to expand modular infrastructure capabilities and capture high-value project pipeline Strategic acquisition would position Safe & Green to expand modular infrastructure capabilities and capture high-value project pipeline

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151241&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=151240&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today provides an update on the timeline for the ongoing clinical trials in its U.S. registration-directed PALISADE Phase 3 Program evaluating fasedienol for acute treatment of social anxiety disorder (SAD). The Company's PALISADE-.

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced xM for treatment response monitoring (TRM), a liquid biopsy assay intended to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in advanced solid tumors. xM for TRM is the newest addition to Tempus' growing portfolio of sensitive assays for monitoring molecular response and minimal residual disease (MRD). It.

KINECT-PRO is the first and only study to specifically evaluate and demonstrate patient-reported improvement with vesicular monoamine transporter 2 inhibitor treatment on tardive dyskinesia using multiple clinically validated scales Patients taking INGREZZA reported robust and clinically meaningful improvements in physical, social and emotional functioning Improvements were seen as early as Week 4 after initial treatment with the lowest INGREZZA dose and sustained through Week 24 Even patients with milder uncontrolled movement severity were negatively impacted by their tardive dyskinesia at baseline and demonstrated meaningful improvements in tardive dyskinesia impact with INGREZZA treatment SAN DIEGO , June 2, 2025 /PRNewswire/ -- …

SINGAPORE, June 02, 2025 (GLOBE NEWSWIRE) -- SAIHEAT Limited (“SAIHEAT” or the “Company”) (NASDAQ: SAIH, SAITW), is pleased to announce that the International Atomic Energy Agency (“IAEA”) has officially approved SAIHEAT as a vendor of small modular reactors (“SMRs”), endorsing the conceptual design and reactor description submitted by the Company.

Realty Income offers a reliable 5.69% yield, 659 consecutive monthly dividends, and 110 quarterly increases, making it a core SWAN holding for income investors. Its diversified portfolio of 15,600+ properties across 91 industries and 98.5% occupancy ensures stability and resilience through economic cycles. With the Fed expected to cut rates in 2025, Realty Income's yield and dividend growth become increasingly attractive versus risk-free alternatives.

Since my March 2024 article, AVGO stock soared 44%, crushing the S&P 500. I'm now reiterating my "Buy" before Broadcom's Q2 FY25 earnings. Broadcom's Q1 AI revenue soared ~77% YoY ($4.1B), fueling a strong beat. CEO eyes expanding AI SAM beyond $75B with new hyperscaler engagements, guiding Q2 AI up 44%. VMware software transition boosts margins. Recovering broadband and growing server storage, plus strong Q1/Q2 bookings, signal a robust 2H 2025 for non-AI segments.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (“NYMT” or the “Company”) today announced that it is soliciting consents (the “Consent Solicitation”) from holders of its outstanding 5.75% Senior Notes due 2026 (the “Notes”) as of 5:00 p.m. New York City time, on May 30, 2025 (the “Record Date”) to a proposed amendment to the indenture governing such Notes (the “Indenture”). The Consent Solicitation is being made solely upon the terms and conditions described in the Company's Consent Solicitation Statement, dated June 2, 2025 (the “Consent Solicitation Statement”). The Consent Solicitation will expire …

Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human dosing in the first half of 2026 MIAMI, FL / ACCESS Newswire / June 2, 2025 / Telomir Pharmaceuticals, Inc. (Nasdaq:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced its participation in the BIO International Convention 2025, taking place in Boston, MA from June 16-19, 2025. The Company has scheduled a full week of BIO One-on-One Partnering™ meetings to explore strategic collaborations, licensing opportunities, and potential M&A transactions.

NEW YORK , June 2, 2025 /PRNewswire/ -- Nukkleus Inc. (NASDAQ: NUKK), which is pursuing a highly disciplined global M&A strategy in the Aerospace & Defense (A&D) industry, today announced that its management team will be presenting at two upcoming investor conferences. June 4: MicroCap Rodeo Conference (in person event to be held at Sparks Steakhouse in NYC)Nukkleus' main presentation is scheduled for 1:00 pm ET.

Tesla Inc (NASDAQ:TSLA) stock was marked down 1.6% ahead of Monday's opening bell, following fresh data showing another sharp decline in car sales across much of Europe. May marked the fifth straight month of falling registrations for the company, with steep drops in markets including Sweden, Portugal, Denmark and France.

JPMorgan Chase CEO Jamie Dimon said on Monday that the rising U.S. national debt is going to create a "tough time" for the bond market and could eventually cause spreads to widen, he told Fox Business' "Mornings with Maria" program.

Tech giants like INTU, APH, AVGO, TWLO and UI surged over 11% in May, powering markets past the "Sell in May" adage with standout gains.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Digimarc Corporation (NASDAQ:DMRC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/digimarc-corporation-lawsuit-submission-form-2?prid=151233&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151234&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your NET Power, Inc. (NYSE:NPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/net-power-inc-lawsuit-submission-form?prid=151235&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=151236&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.